相关实验视频
Updated: Feb 3, 2026

07:40
A Murine Model of Subarachnoid Hemorrhage
Published on: November 21, 2013
20.5K
为什么神经瘤下大脑关节出血患者会推迟治疗?
Ksenia Yarova1, Yuliia Solodovnikova1
1Department of Neurology and Neurosurgery, Odesa National Medical University, Tinysta Str. 8, Odesa, Ukraine, 65009.
World neurosurgery
|February 1, 2026
概括
脑动脉动脉瘤 (CAA) 破裂的延迟诊断,特别是在复发的情况下,与非焦点症状和社会障碍有关. 专家的及时医疗评估大大减少了诊断延迟.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 公共卫生 公共卫生
背景情况:
- 脑动脉动脉瘤 (CAA) 破裂的早期诊断对于改善患者的预后和降低死亡率至关重要.
- 经常发生的断裂显著加重了结果,但诊断时间因症状呈现而有很大差异.
- 了解影响寻求帮助行为的因素对于及时诊断CAA破裂至关重要.
研究的目的:
- 在经历反复脑动脉动脉瘤断裂的患者中确定寻求帮助行为的预测因素.
- 分析导致脑动脉动脉瘤破裂病例诊断延迟的因素.
主要方法:
- 从2000年到2023年,对448名脑动脉动脉瘤破裂 (CAA) 患者进行了回顾性分析.
- 患者被分为单次与复发性破裂组;医院前期定义为从第一次破裂到诊断的时间.
- 评估社会人口结构,CAA特征,神经症状以及医生专业对诊断及时性的影响.
主要成果:
- 在复发性CAA破裂患者中观察到显著的诊断延迟,验证比单次破裂病例晚5-6天.
- 反复出现的雷声头痛矛盾地延长了诊断时间,而严重的症状 (,,LOC) 则使诊断时间加速了12-23天.
- 神经科医生/神经外科医生的评估减少了~7天的延迟;非专家的错误诊断导致~10天的延迟.
结论:
- 非焦点症状,女性性别和社会心理障碍是CAA破裂延迟咨询的关键预测因素.
- 改善早期诊断和提高患者对CAA风险的认识是基本的公共卫生目标.
- 专家评估对于减少脑动脉动脉瘤破裂的诊断延迟至关重要.
相关概念视频
Aneurysm I: Introduction
416
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
416
Aneurysm IV: Nursing Management
474
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
474
Aneurysm III: Interprofessional Care
307
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
307
Aneurysm II: Clinical Manifestations and Diagnostic Studies
349
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
349
Open Angle Glaucoma: Treatment
997
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
997
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

